Angiogenic factor thymidine phosphorylase increases cancer cell invasion activity in patients with gastric adenocarcinoma

Molecular Cancer Research

Volumn 6, Issue 10, 2008, Pages 1554-1566

  Eun, Jeong Yu ^a,b   Lee, Young ^a   Sun, Young Rha ^a,b   Tae, Soo Kim ^a   Hyun, Cheol Chung ^a,b   Bong, Kyeong Oh ^a   Woo, Ick Yang ^b   Sung, Hoon Noh ^a,b   Jeung, Hei Cheul ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANTIMETASTATIC AGENT; DEOXYRIBOSE; PHOSPHATIDYLINOSITOL 3 KINASE; RAPAMYCIN; THYMIDINE PHOSPHORYLASE; THYMIDINE PHOSPHORYLASE INHIBITOR; UNCLASSIFIED DRUG; WORTMANNIN;

ACTIN FILAMENT; ARTICLE; CANCER INVASION; CELL ADHESION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; METASTASIS INHIBITION; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACTINS; ADENOCARCINOMA; ANGIOGENESIS INDUCING AGENTS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; COLLAGEN; DEOXYRIBOSE; DRUG COMBINATIONS; DRUG SYNERGISM; ENZYME INHIBITORS; HUMANS; LAMININ; NEOPLASM INVASIVENESS; PROTEIN KINASES; PROTEOGLYCANS; RECOMBINANT PROTEINS; STOMACH NEOPLASMS; THYMIDINE PHOSPHORYLASE;

EID: 54249149356     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-08-0166     Document Type: Article

References (40)

1. Akiyama S, Furukawa T, Sumizawa T, et al. The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression. Cancer Sci 2004; 95:851-7.
2. Uchimiya H, Furukawa T, Okamoto M, et al. Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L- ribose. Cancer Res 2002;62:2834-9.
3. Kitazono M, Takebayashi Y, Ishitsuka K, et al. Prevention of hypoxia-induced apoptosis by the angiogenic factor thymidine phosphorylase. Biochem Biophys Res Commun 1998;253:797-803.
4. Takebayashi Y, Yamada K, Miyadera K, et al. The activity and expression of thymidine phosphorylase in human solid tumours. Eur J Cancer 1996;32A: 1227-32.
5. Toi M, Rahman MA, Bando H, Chow LWC. Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment. Lancet Oncol 2005;6:158-66.
6. Maeda K, Kang SM, Ogawa M, et al. Combined analysis of vascular endothelial growth factor and platelet-derived endothelial cell growth factor expression in gastric cancer. Int J Cancer 1997;74:545-50.
7. Takebayashi Y, Miyadera K, Akiyama S, et al. Expression of thymidine phosphorylase in human gastric carcinoma. Jpn J Cancer Res 1996;87: 288-95.
8. Takao S, Takebayashi, Che X, et al. Expression of thymidine phosphorylase is associated with a poor prognosis in patients with ductal adenocarcinoma of the pancreas. Clin Cancer Res 1998;4:1619-24.
9. O'Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res 1995; 55:510-3.
10. Jones A, Fujiyama C, Turner K, et al. Role of thymidine phosphorylase in an in vitro model of human bladder cancer invasion. J Urol 2002;167: 1482-6.
11. Nakajima Y, Gotanda T, Uchimiya H, et al. Inhibition of metastasis of tumor cells overexpressing thymidine phosphorylase by 2-deoxy-L-ribose. Cancer Res 2004;64:1794-801.
12. Takao S, Akiyama SI, Nakajo A, et al. Suppression of metastasis by thymidine phosphorylase inhibitors. Cancer Res 2000;60:5345-8.
13. Nakajima Y, Haraquchi M, Furukawa T, et al. 2-Deoxy-L-ribose inhibits the invasion of thymidine phosphorylase-overexpressing tumors by suppressing matrix metalloproteinase-9. Int J Cancer 2006;119:1710-6.
14. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999;83:18-29.
15. Qian Y, Corum L, Meng Q, et al. PI3K induced actin filament remodeling through Akt and p70S6K1: implication of essential role in cell migration. Am J Physiol Cell Physiol 2004;286:153-63.
16. Berven LA, Willard FS, Crouch MF. Role of the p70S6K pathway in regulating the actin cytoskeleton and cell migration. Exp Cell Res 2004;296: 183-95.
17. Brown NS, Bicknell R. Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis. Biochem J 1998;334:1-8.
18. Desgranges C, Razaka G, Rabaud M, Bricaud H. Catabolism of thymidine in human blood platelets: purification and properties of thymidine phosphorylase. Biochim Biophys Acta 1981;654:211-8.
19. Hotchkiss KA, Ashton AW, Klein RS, Lenzi ML, Zhu GH, Schwartz EL. Mechanisms by which tumor cells and monocytes expressing the angiogenic factor thymidine phosphorylase mediate human endothelial cell migration. Cancer Res 2003;63:527-33.
20. Pauly JL, Schuller MG, Zelcer AA, Kirss TA, Gore SS, Germain MJ. Identification and comparative analysis of thymidine phosphorylase in the plasma of healthy subjects and cancer patients. J Natl Cancer Inst 1977;58: 1587-90.
21. Shaw T, Smillie RH, Macphee DG. The role of blood platelets in nucleoside metabolism: assay, cellular location and significance of thymidine phosphorylase in human blood. Mutat Res 1988;200:99-116.
22. Jeung HC, Che XF, Haraguchi M, et al. Thymidine phosphorylase suppresses apoptosis induced by microtubule-interfering agents. Biochem Pharmacol 2005; 70:13-21.
23. Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R. Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors. Cancer Res 2000;60:6298-302.
24. Ueda M, Terai Y, Kumagai K, Ueki K, Kanemura M, Ueki M. Correlation between thymidine phosphorylase expression and invasion phenotype in cervical carcinoma cells. Int J Cancer 2001;91:778-82.
25. Hotchkiss KA, Ashton AW, SchwartzEL. Thymidine phosphorylase and 2-deoxyribose stimulate human endothelial cell migration by specific activation of the integrins α5β1 and αVβ3. J Biol Chem 2003;278:19272-9.
26. Kornberg LJ. Focal adhesion kinase and its potential involvement in tumor invasion and metastasis. Head Neck 1998;20:745-52.
27. Gabarra-Niecko V, Schaller MD, Dunty JM. FAK regulates biological process important for the pathogenesis of cancer. Cancer Metastasis Rev 2003;22: 359-74.
28. Burdett E, Klip A. Exofacial regions of the glucose transporter of human erythrocytes: detection with polyclonal antibodies. Biochem Cell Biol 1988;66: 1126-33.
29. Kim HD, McManus TJ. Studies on the energy metabolism of pig red cell. II. Lactate formation from free ribose and deoxyribose with maintenance of ATP. Biochim Biophys Acta 1971;230:12-9.
30. Poon M, Marx SO, Gallo R, Badimon JJ, Taubman MB, Marks AR. Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest 1996;98: 2277-83.
31. Sun J, Marx SO, Chen HJ, Poon M, Marks AR, Rabbani LE. Role for p27(Kip1) in vascular smooth muscle cell migration. Circulation 2001;103: 2967-72.
32. Seeliger H, Guba M, Koehl GE, et al. Blockage of 2-deoxy-D- ribose-induced angiogenesis with rapamycin counteracts a thymidine phosphorylase-based escape mechanism available for colon cancer under 5-fluorouracil therapy. Clin Cancer Res 2004;10:1843-52.
33. Moghaddam A, Zhang HT, Fan TP, et al. Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci U S A 1995;92: 998-1002.
34. Sato J, Sata M, Nakamura H, et al. Role and thymidine phosphorylase on invasiveness and metastasis in lung adenocarcinoma. Int J Cancer 2003; 106:863-70.
35. Igawa H, Fujieda S, Kimura Y, et al. Influence of platelet-derived endothelial cell growth factor/thymidine phosphorylase on the cell cycle in head and neck squamous cell carcinoma in vitro. Oncol Rep 2003;10:967-71.
36. Heldin NE, Usuki K, Bergh J, Westermark B, Heldin CH. Differential expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human lung carcinoma cell lines. Br J Cancer 1993;68:708-11.
37. Reynolds K, Farzaneh F, Collins WP, et al. Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J Natl Cancer Inst 1994;86:1234-8.
38. Kim J, Lee YH, Kwon TK, Chang JS, Chung KC, Min DS. Phospholipase D prevents etoposide-induced apoptosis by inhibiting the expression of early growth response-1 and phosphatase and tensin homologue deleted on chromosome 10. Cancer Res 2006;66:784-93.
39. Jeung HC, Che XF, Haraguchi M, et al. Protection against DNA damage-induced apoptosis by the angiogenic factor thymidine phosphorylase. FEBS Lett 2006;580:1294-302.
40. Temmink OH, Emura T, de Bruin M, Fukushima M, Peters GJ. Therapeutic potential of the dual-targeted TAS-102 formation in the treatment of gastrointestinal malignancies. Cancer Sci 2007;98:779-89.